cancer biology Archives - Cold Spring Harbor Laboratory

Newsstand Menu

Select stories by tag

One experiment: Observing cancer’s progress in a mouse prostate

March 14, 2019

Using a technique originally designed for mapping brains, two CSHL labs have worked together to image cancer progression in a mouse prostate.

Nation’s cancer centers endorse HPV vaccination

June 8, 2018

Dr. Stillman and Dr. Tuveson joined with the leaders of other institutions nationwide in endorsing a statement regarding the HPV vaccine

Hannon named director of Cancer Research UK Cambridge Institute

November 21, 2017

Dr. Greg Hannon has been named the new director of the Cancer Research UK Cambridge Institute, effective February 1, 2018.

Freeze-frames of enzymes in action have implications for a new cancer treatment concept

July 3, 2017

TUTase enzymes interact with let-7, a regulator of development; targeting them could help control certain cancers.

A protein that stem cells require could be a target in killing breast cancer cells

June 1, 2017

Cancer cells, like stem cells, have the ability to multiply indefinitely but epigenetic factor BPTF may be a shared weakness.

CSHL to lead international team developing next-generation organoid cancer research

May 11, 2017

Cold Spring Harbor Laboratory (CSHL) has been awarded a research subcontract by Leidos Biomedical Research to lead a Cancer Model Development Center (CMDC) for pancreatic, breast, colorectal, lung, liver and other upper-gastrointestinal cancers.

Newly discovered mutations impair key cell pathways in pancreatic cancer

May 8, 2017

Researchers have found important new clues to the development of pancreatic cancer.

Pershing Square Sohn cancer research prize awarded to CSHL’s Dr. Mikala Egeblad

May 8, 2017

Cold Spring Harbor Laboratory (CSHL) Associate Professor Mikala Egeblad, Ph.D., has been awarded the Pershing Square Sohn Prize.

New research explains why even targeted therapies eventually fail in lung cancer

March 29, 2017

Dr. Sordella and her team propose a novel theory of how some cancers circumvent the killing power of targeted therapies.

Researchers identify “Achilles’ heel” of PTEN that helps drive prostate cancer progression

February 13, 2017

Researchers at CSHL have discovered that a protein called Importin-11 protects the anti-cancer protein PTEN from destruction by transporting it.

Cancer research biobank formed by Northwell Health and Indivumed will enhance CSHL-Northwell alliance

January 17, 2017

Northwell Health and Indivumed collaborate to greatly expand cancer biobanking activities within Northwell Health to develop medical approaches.

Relationship between incorrect chromosome number and cancer is reassessed after surprising experiments

January 12, 2017

Pre-malignant aneuploid cells grew more slowly and formed smaller tumors than comparable cells with normal chromosome number, CSHL researchers found.

CSHL joins NCI-designated cancer centers in endorsing updated HPV vaccination recommendations

January 11, 2017

Dr. Stillman and Dr. Tuveson joined with the leaders of other institutions nationwide in endorsing a statement regarding the HPV vaccine.

<em>Incurable</em>’s remarkable book party

Incurable’s remarkable book party

May 25, 2011

Incurable: A Life After Diagnosis, from CSHL Press, follows trustee Charlie Harris's thoughts post-cancer diagnosis.

CSHL study shows that malignant tumors can be shut down after all

November 9, 2009

Aggressive tumors lacking p53 protein stop dead in their tracks when p53’s sister protein—TAp63—steps in.

CSHL Story archive for Tag: cancer biology